Contractor profile
PARTNER THERAPEUTICS, INC.
Active registrationSmall Business
UEIJ33MSDBJZMC6
CAGE code7ZTL0
Primary NAICS325412
LocationLEXINGTON, MA, 02421
Federal obligations$147M
Prime awards7
Active awards2
Latest award actionJun 16, 2026
Federal award activity
Public award recordTop federal customers
- Department of Health and Human Services3 awards$147M
- Department of Veterans Affairs4 awards$163,266
NAICS award mix
- 3254125 awards$134M
- 5417151 awards$13M
- 5417141 awards$748,039
PSC award mix
- 65151 awards$134M
- AN131 awards$13M
- AN151 awards$748,039
- 65054 awards$163,266
Contract vehicles
- 36F79723D01714 awards$134M
Potential recompetes
- Department of Health and Human Services$134M
- Department of Health and Human Services$13M
Prime award history
| Award | Agency / office | Category | Value | Dates |
|---|---|---|---|---|
| 36C24626N0782EMERG. BIZENGRI MEDS FOR VETERAN | Department of Veterans Affairs246-NETWORK CONTRACTING OFFICE 6 (36C246) | NAICS 325412PSC 6505 | $72,563 | Jun 16, 2026 – Jul 10, 2026 |
| 75A50323F80027LEUKINE 250MCG VIL INJ (5PKG) | Department of Health and Human ServicesASPR/ORM-SNS | NAICS 325412PSC 6515 | $134M | Sep 26, 2023 – Mar 29, 2027 |
| 36F79723D017165 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans AffairsNAC FEDERAL SUPPLY SCHEDULE (36F797) | NAICS 325412PSC 6505 | $0 | Aug 15, 2023 – Not stated |
| 36C24626N0690EMERGENCY BIZENGRI MEDS. FOR VETERAN | Department of Veterans Affairs246-NETWORK CONTRACTING OFFICE 6 (36C246) | NAICS 325412PSC 6505 | $54,422 | May 5, 2026 – May 19, 2026 |
| 36C24626N0637EMERGENCY BIZENGRI MEDS FOR VETERAN | Department of Veterans Affairs246-NETWORK CONTRACTING OFFICE 6 (36C246) | NAICS 325412PSC 6505 | $36,281 | Apr 10, 2026 – Apr 24, 2026 |
| 75A50124C00061PARTNER THERAPEUTICS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO CONFIRM LEUKINE SAFETY IN SEPSIS PATIENTS, INFORM OPTIMAL LEUKINE DOSING, EXPLORE LEUKINE EFFICACY, AS WELL AS ADVANCE DEVELOPMENT OF MONOCYTE HUMAN LEUKOCYTE ANTIGEN-DR (MHLA-DR) AS | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | NAICS 541715PSC AN13 | $13M | Sep 30, 2024 – Sep 30, 2028 |
| 75A50123C00064R&D FOR REPURPOSING FX06, A HOST-DIRECTED THERAPY, FOR TREATMENT OF SEVERE DISEASE IN PATIENTS WITH SUDAN VIRUS DISEASE (SVD) OR OTHER FILOVIRUSES AOI #22 REBOOT | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | NAICS 541714PSC AN15 | $748,039 | Sep 25, 2023 – Jan 30, 2026 |
Award links and obligation totals come from USAspending.gov public records.
Industries and classifications
Public points of contact
JOHN MULROYGovernment business
JOHN MULROYElectronic business
Names and titles are reproduced from the public registration. FedRoster does not guess or enrich personal contact details.